Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Anemia 3 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Neoplasms, Plasma Cell 1 Mycosis Fungoides 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Mast-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Hairy Cell 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Leiomyoma 1

Interventions

ulipristal acetate 20 Uterine Myomectomy 19 telapristone acetate 18 vilaprisan 12 relugolix 12 Leuprolide 11 Uterine Artery Embolization 10 estradiol, norethindrone drug combination 9 asoprisnil 9 Estradiol 8 elagolix 7 Tranexamic Acid 7 Mifepristone 7 Bupivacaine 7 ulipristal 6 Norethindrone Acetate 6 Hysterectomy 6 Saline Solution 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Misoprostol 4 Letrozole 4 Vitamin B 6 3 Tablets 3 Surveys and Questionnaires 3 Sugars 3 Radiofrequency Ablation 3 Lidocaine 3 Hysteroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyoma × ferrous sulfate × Clear all

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡